Infectious Agents And Cancer
簡(jiǎn)稱(chēng)：INFECT AGENTS CANCER
ISSN：1750-9378
ESSN：1750-9378
研究方向：ONCOLOGY - IMMUNOLOGY
所屬分區(qū)：3區(qū)
出版地：ENGLAND
出版周期：1 issue/year
創(chuàng)刊時(shí)間：2006
Infectious Agents And Cancer英文簡(jiǎn)介
Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.
The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:
? HPV and anogenital cancers, as well as head and neck cancers;
? EBV and Burkitt lymphoma;
? HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;
? HHV8 and Kaposi sarcoma;
? HTLV and leukemia;
? Cancers in Low- and Middle-income countries.
The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.
Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.
Infectious Agents And Cancer中文簡(jiǎn)介
《Infectious Agents And Cancer》是一本由BMC出版商出版的專(zhuān)業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于2006年，刊期1 issue/year，該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄。在中科院最新升級(jí)版分區(qū)表中，該刊分區(qū)信息為大類(lèi)學(xué)科：醫(yī)學(xué) 4區(qū)，小類(lèi)學(xué)科：免疫學(xué) 4區(qū)；腫瘤學(xué) 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級(jí)為Q3。該刊發(fā)文范圍涵蓋免疫學(xué)等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國(guó)內(nèi)外免疫學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為3.698，平均審稿速度17 Weeks。
中科院分區(qū)最新升級(jí)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級(jí)版）
| 大類(lèi)學(xué)科 | 分區(qū) | 小類(lèi)學(xué)科 | 分區(qū) | Top期刊 | 綜述期刊 |
| 醫(yī)學(xué) | 4區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 4區(qū) 4區(qū) | 否 | 否 |
中科院分區(qū)最新基礎(chǔ)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新基礎(chǔ)版）
| 大類(lèi)學(xué)科 | 分區(qū) | 小類(lèi)學(xué)科 | 分區(qū) | Top期刊 | 綜述期刊 |
| 醫(yī)學(xué) | 3區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 4區(qū) 4區(qū) | 否 | 否 |
中科院JCR分區(qū)歷年趨勢(shì)圖
JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）
| JCR分區(qū)等級(jí) | JCR所屬學(xué)科 | 分區(qū) | 影響因子 |
| Q3 | IMMUNOLOGY | Q3 | 3.698 |
| ONCOLOGY | Q3 |
期刊指數(shù)
| 影響因子 | h-index | Gold OA文章占比 | 研究類(lèi)文章占比 | OA開(kāi)放訪問(wèn) | 平均審稿速度 |
| 3.698 | 30 | 100.00% | 84.85% | 開(kāi)放 | 17 Weeks |